Premium
Use of prechemotherapy positron emission tomography‐CT imaging, acquired in the treatment position, to help plan involved nodal radiotherapy for a patient with diffuse large B‐cell lymphoma
Author(s) -
David Steven P,
Rees Heather S,
MacManus Michael P
Publication year - 2011
Publication title -
journal of medical imaging and radiation oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 43
eISSN - 1754-9485
pISSN - 1754-9477
DOI - 10.1111/j.1754-9485.2011.02257.x
Subject(s) - medicine , positron emission tomography , radiation therapy , lymphoma , radiology , nuclear medicine , radiation treatment planning , diffuse large b cell lymphoma , fluorodeoxyglucose , tomography , positron emission tomography computed tomography , medical physics , pathology
Summary Fused positron emission tomography/computed tomography (PET‐CT) images are increasingly being used to assist radiation oncologists in the definition of treatment volumes for patients with metabolically active tumours. This is the first report in which baseline fluorodeoxyglucose‐PET‐CT images were acquired in the treatment position in a case of diffuse large B‐cell lymphoma and incorporated directly into the radiotherapy treatment planning process. It highlights the potential benefits of using combined 3‐D functional and structural imaging for the design of radiation target volumes in patients with aggressive lymphomas that are managed with combined chemo and radiotherapy.